C. L. Bladen Et Al. , "The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia," HUMAN MUTATION , vol.34, no.11, pp.1449-1457, 2013
Bladen, C. L. Et Al. 2013. The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia. HUMAN MUTATION , vol.34, no.11 , 1449-1457.
Bladen, C. L., Rafferty, K., Straub, V., Monges, S., Moresco, A., Dawkins, H., ... Roy, A.(2013). The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia. HUMAN MUTATION , vol.34, no.11, 1449-1457.
Bladen, Catherine Et Al. "The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia," HUMAN MUTATION , vol.34, no.11, 1449-1457, 2013
Bladen, Catherine L. Et Al. "The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia." HUMAN MUTATION , vol.34, no.11, pp.1449-1457, 2013
Bladen, C. L. Et Al. (2013) . "The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia." HUMAN MUTATION , vol.34, no.11, pp.1449-1457.
@article{article, author={Catherine L. Bladen Et Al. }, title={The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia}, journal={HUMAN MUTATION}, year=2013, pages={1449-1457} }